Format

Send to

Choose Destination
Mol Cell Probes. 2019 Apr;44:37-43. doi: 10.1016/j.mcp.2019.02.001. Epub 2019 Feb 5.

MiR-486-5p inhibits the proliferation of leukemia cells and induces apoptosis through targeting FOXO1.

Author information

1
Department of Hematology, The First Affiliated Hospital of Xi'an Medical University, China.
2
Department of Hematology, The First Affiliated Hospital of Xi'an Medical University, China. Electronic address: jianqiang_zhj@163.com.

Abstract

AIM:

Studies have reported that micro (miR)-486-5p plays a crucial part in the progression of leukemia, however, to the best of our knowledge, few studies have been conducted on its mechanism in leukemia. In this study, the mechanism of miR-486-5p in leukemia cells was pointed out and its possible target genes were analyzed for the purpose of providing new therapeutic strategies for treating leukemia patients.

METHODS:

MiRNA expression of Leukemia cells (K562, Kasumi-1, and THP-1) and primary leukocytes was detected by Real-time Quantitative polymerase chain reaction(qPCR). The activity of the cells was assessed using the Cell Counting Kit-8 (CCK-8). Apoptotic cells were analyzed by a flow cytometer (FCM). Caspase-3 activation in leukemia cells was determined by Western blot. Targetscan 7.2 was used to predict the potential targets of miR-486-5p and further confirmed by dual-luciferase reporter assay.

RESULT:

miR-486-5p was significantly down-regulated in leukemia cells. The over-expression of miR-486-5p notably increased the apoptosis and caspase-3 activity in leukemia cells. There was a predicted interaction site for miR-486-5p in the FOXO1 3'-UTR. Furthermore, this study showed that FOXO1 was significantly up-regulated in leukemia cells, the growth of which was depressed by the up-regulation of miR-486-5p.

CONCLUSION:

miR-486-5p may inhibit the proliferation of leukemia cells and induce apoptosis through targeting FOXO1.

KEYWORDS:

Apoptosis; FOXO1; Leukemia cells; Proliferation; miR-486-5p

PMID:
30731134
DOI:
10.1016/j.mcp.2019.02.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center